Search Results 1141-1150 of 15590 for Orange Peel tea

  1. A Study To Evaluate Durvalumab Plus Topotecan Or Lurbinectedin In Patients With Small Cell Lung Cancer - Mayo Clinic

    EXCEPTIONS: Non-melanotic skin cancer, papillary thyroid cancer, or carcinoma-in-situ of the cervix, or others curatively treated and now considered to be ...

  2. Clinical trials - Gastroenterology and Hepatology

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  3. A Placebo-Controlled Study Of Oral Ozanimod As Maintenance Therapy For Moderately To Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study To Investigate The Safety, Tolerability, Pharmacokinetics, And Anti-tumor Activity Of CBI-1214 T Cell Engager In Participants With Advanced Or Metastatic MSS/MSI-L Colorectal Cancer - Mayo Clinic

    Clinical Trials · A Study To Investigate The Safety, Tolerability, Pharmacokinetics, And Anti-tumor Activity Of CBI-1214 T Cell Engager In Participants With ...

  5. A Global, Randomized, Placebo-controlled Phase 3 Study Of Fruquintinib In Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    The purpose of this study is to compare the effectiveness and safety of fruquintinib plus best supportive care (BSC) versus placebo plus BSC in patients with ...

  6. A Randomized Phase 2 Trial Of Axitinib And TRC105 Versus Axitinib Alone In Patients With Advanced Or Metastatic Renal Cell Carcinoma - Mayo Clinic

    No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, adequately treated Stage I or II ...

  7. Doctors & Departments - Mayo Clinic

    Research · Noncyclical breast pain. · Hot flashes. · Low-back pain and sciatica. · Prevention of nausea in people having cardiac surgery.

  8. MC250711 A Study Of WSD0922-FU When Combined With Adjuvant Temozolomide In EGFR Mutant Glioblastoma - Mayo Clinic

    The purpose of this study is to assess if adding WSD0922-FU to adjuvant temozolomide improves progression-free survival (PFS) compared to standard of care (SOC) ...

  9. Simtuzumab (GS-6624) In The Treatment Of Cirrhosis Due To NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

  10. A Study Of X4P-001 In Patients With Advanced Renal Cell Carcinoma - Mayo Clinic

    Completely resected basal cell and squamous cell skin cancers;; Any malignancy considered to be indolent and that has never required therapy;; Completely ...